Arkin Bio Venture Partners Ltd.

Insider CIK 1808349 · KROS 10% owner

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
KROS Keros Therapeutics, Inc.	C Conversion deriv	2020-04-13	2020-04-13	167,537	—	$0	0	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion deriv	2020-04-13	2020-04-13	343,270	—	$0	0	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion deriv	2020-04-13	2020-04-13	1,382,295	—	$0	0	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion	2020-04-13	2020-04-13	1,382,295	—	$0	1,382,295	SEC↗
KROS Keros Therapeutics, Inc.	P Buy	2020-04-13	2020-04-13	120,000	$16.00	$1.92M	2,013,102	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion	2020-04-13	2020-04-13	343,270	—	$0	1,725,565	SEC↗
KROS Keros Therapeutics, Inc.	C Conversion	2020-04-13	2020-04-13	167,537	—	$0	1,893,102	SEC↗